TORONTO--(BUSINESS WIRE)--Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on Parkinson’s disease, announced that it will host an Analyst and Investor Breakfast featuring presentations by executive management and a clinical key opinion leader on Wednesday, March 18, 2015 at 7:30 a.m. in New York City.
•Members of Cynapsus Therapeutics’ executive management team will provide an overview of APL-130277, the Company’s easy-to-use, fast-acting formulation of apomorphine for the on-demand treatment of OFF episodes in Parkinson’s disease patients, as well as the company;
Help employers find you! Check out all the jobs and post your resume.
